The absence of the chloride channel CLC-3 in Clcn3 −/− mice results in hippocampal degeneration with a distinct temporal-spatial sequence that resembles neuronal loss in temporal lobe epilepsy. We examined how the loss of CLC-3 might affect GABAergic synaptic transmission in the hippocampus. An electrophysiological study of synaptic function in hippocampal slices taken from Clcn3 −/− mice before the onset of neurodegeneration revealed a substantial decrease in the amplitude and frequency of miniature inhibitory postsynaptic currents compared with those in wild-type slices. We found that CLC-3 colocalized with the vesicular GABA transporter VGAT in the CA1 region of the hippocampus. Acidification of inhibitory synaptic vesicles induced by Cl − showed a marked dependence on CLC-3 expression. The decrease in inhibitory transmission in Clcn3 −/− mice suggests that the neurotransmitter loading of synaptic vesicles was reduced, which we attribute to defective vesicular acidification. Our observations extend the role of Cl − in inhibitory transmission from that of a postsynaptic permeant species to a presynaptic regulatory element.
a r t I C l e S CLC-3 chloride channels are members of an extended family of voltage-gated chloride channels and transporters and are ubiquitously expressed throughout the brain. The CLC-3 knockout (Clcn3 −/− ) mouse shows complete postnatal neurodegeneration of the hippocampus [1] [2] [3] with a temporal-spatial sequence that suggests a strong relationship to network connectivity 2 . The hippocampal formation appears normal up to and including the fourth postnatal week in development, which indicates that Clcn3 −/− mice can generate a properly structured CNS. Loss of hippocampal neurons becomes evident by postnatal week 12, with the most severe loss occurring in the dentate gyrus and region CA1 (ref. 2) . By the time the mice are 12 months old, the hippocampal formation has degenerated completely and the lateral ventricles have become progressively enlarged. This profound and developmentally delayed neuronal degeneration provides a tool with which to examine the physiological role of CLC-3 in brain maturation.
CLC-3 channels are localized at both pre-and postsynaptic sites, where they can provide an important level of regulation in the modulation of synaptic plasticity. Presynaptically, CLC-3 has been localized to synaptic vesicles, where it has been suggested that the channel contributes to both synaptic vesicle pH regulation and transmitter filling 1, 4, 5 . This hypothesis remains controversial, at least for the glutamatergic system 6 . Postsynaptically, CLC-3 channels have been localized to glutamatergic synapses in the hippocampus, where they augment synaptic efficacy as a function of changes in postsynaptic Cl − homeostasis 4 . As determinants of cell function, an enhancement of CLC-3 expression during cell division has recently shown that the channel is essential for both normal and malignant glial cell division 7 and migration 8 .
Our studies are targeted at an integrated understanding of the role of CLC-3 in fundamental aspects of hippocampal neuronal excitability.
Localization of the channel in hippocampal slices at perisomatic inhibitory synapses in CA1 neurons suggested that deficiencies in CLC-3 expression that have been implicated in changes in GABAergic signaling 2 in the forebrain might contribute to the early stages of neurodegeneration. To investigate whether ClC-3 has a physiological role in inhibitory transmission, we began by comparing inhibitory activity in hippocampal brain slices taken from Clcn3 −/− mice before the onset of observable neurodegeneration with activity in slices from Clcn3 +/+ mice. Slices from Clcn3 −/− mice showed significantly lower miniature postsynaptic currents (mIPSC) frequency and quantal size (P < 0.005 for frequency, P < 0.001 for quantal size), suggesting that there is a distinct presynaptic CLC-3-dependent regulatory mechanism.
Previous studies carried out on the purified, reconstituted vesicular inhibitory amino acid transporter (VGAT) have suggested that the inhibitory transmitter GABA is transported into proteoliposomes along with two equivalents of external Cl − (ref. 9) . To determine whether CLC-3 expressed in inhibitory synaptic vesicles provides a parallel Cl − entry pathway, we examined immunoisolated inhibitory vesicles from Clcn3 −/− and Clcn3 +/+ mice. In addition, we created a rat model for the Clcn3 −/− vesicles to circumvent possible neurodegenerative changes in transporter protein expression seen in the Clcn3 −/− mice. CLC-3 indeed enhanced vesicle acidification rate and amplitude, supporting that idea that CLC-3 has a presynaptic role in the regulation of quantal size at inhibitory synapses.
RESULTS
Co-localization of CLC-3 with VGAT at hippocampal synapses Immunohistochemistry on slice preparations in the CA1 stratum pyramidale revealed a prominent, punctate pattern of perisomatic a r t I C l e S CLC-3 staining (Fig. 1a) . As most of the perisomatic innervation of CA1 hippocampal pyramidal cells is derived from inhibitory synapses 10 and CLC-3 is expressed in synaptic vesicles 1, 4 , we compared immunoreactivity for CLC-3 and VGAT in hippocampal slices. Confocal doublelabeling studies showed less prominent CLC-3 expression in the stratum radiatum and stratum oriens (Fig. 1b) , with a high degree of overlap between anti-VGAT staining (Fig. 1c) and CLC-3 (correlation coefficient 0.92; merged images in Fig. 1d,e) . There was a similar degree of overlap between CLC-3 and VGLUT1; however, in contrast to that with VGAT, the overlap was concentrated in the stratum radiatum and stratum oriens ( Supplementary Fig. 1 and Supplementary Table 1) .
High levels of expression of CLC-3 at synaptic sites and the limits of resolution of light microscopy made it difficult to localize CLC-3 to synaptic vesicles, as suggested by the colocalization with VGAT. To compartmentalize its subsynaptic location and expression further, we carried out subcellular fractionation of whole rat brains 11 . The population of crude synaptic vesicles (CSVs) appeared homogeneous under electron microscopy ( Fig. 2a) and within the size range described elsewhere for synaptic vesicles 11 . We immunopurified VGAT-positive vesicles using anti-VGAT-coated microbeads and examined them by immuno-electron microscopy. Beads were stained with antibodies to CLC-3 followed by secondary antibodies conjugated to 15-nm gold particles (Fig. 2b) . We saw CLC-3 localized to the bound, immunopurified inhibitory synaptic vesicles (inserts in Fig. 2b ).
Reduced miniature IPSC quantal size in Clcn3 −/− mice Next we tested whether the absence of CLC-3 expression at inhibitory synaptic terminals resulted in changes in synaptic transmission in the CA1 region of acute hippocampal slices from Clcn3 −/− as compared to Clcn3 +/+ mice. We used mice between postnatal day (P)18 and P25 that had no detectable neurodegeneration in the ventral hippocampus. We pharmacologically isolated and analyzed mIPSCs (Fig. 3) . Both the frequency (Fig. 3a,b) and amplitude (Fig. 3c,d ) of mIPSCs were significantly lower in slices from Clcn3 −/− mice as compared to Clcn3 +/+ mice. The cumulative distribution of mIPSC amplitudes was significantly shifted toward smaller events in Clcn3 −/− mice as compared to control mice (Fig. 3d) . Currents recorded in slices from Clcn3 −/− mice were significantly lower in amplitude as compared to currents from Clcn3 +/+ slices (see insert showing comparative box a r t I C l e S plot analysis in Fig. 3d) . The difference in the frequency and size of inhibitory events as a function of CLC-3 expression supports that idea that vesicular CLC-3 determines quantal size. (Fig. 4c,d) .
If the changes in mIPSCs recorded from Clcn3 −/− cells are due to reduced acidification and refilling, we would expect to see similar changes in mIPSC size in Clcn3 +/+ cells in the presence of Tris. In contrast to the fast inhibition observed for the evoked IPSC amplitude, addition of Tris reduced the amplitude of mIPSCs with a marked lag time (20- 30 min; Fig. 4e,f) . In that the events are spontaneous, this process should occur with a lag time as reserve vesicles are released; however, after release, most or all of the recycling vesicles will be filled with Tris. As in Clcn3 −/− cells, we observed left shifts in the peak amplitude histogram and the cumulative probability curve for the events recorded in the presence of Tris (Fig. 4g) . However, unlike Clcn3 −/− cells, Clcn3 +/+ cells in the presence of Tris did not show a significant decrease in event frequency (Fig. 4h) .
To rule out the possibility that changes in postsynaptic GABA receptor density were responsible for the decrease in mIPSC amplitude, we measured the responses to brief puff applications of 10-µM GABA to the cell soma. The amplitudes of evoked GABA currents did not differ significantly between Clcn3 +/+ and Clcn3 −/− neurons ( Supplementary Fig. 2 ).
Slice preparations from Clcn3 +/+ and Clcn3 −/− animals differed significantly in the level of apparent paired-pulse depression (PPD), with the Clcn3 −/− cells showing diminished PPD ( Supplementary  Fig. 3a,b) . In paired-pulse experiments, there is a balance between two processes: depletion of the readily releasable vesicle pool during the first pulse and Ca 2+ -dependent facilitation of release during the second pulse. Changes in PPD (the ratio of the amplitude of the second pulse to that of the first) could reflect a reduction in the amplitude and, therefore, in the release probability during the first pulse. Indeed, IPSCs evoked by identical stimulation intensities induce larger responses in untreated Clcn3 +/+ slices than in Clcn3 −/− slices or Clcn3 +/+ slices treated with 20 mM Tris ( Supplementary Fig. 3c,d ). In Clcn3 +/+ slices, PPD could be diminished to responses similar to those seen in the Clcn3 −/− slices by the addition of high extracellular Tris (Supplementary Fig. 3a,b) . These data suggested that the decreased responses in the Clcn3 −/− slices might be due to aberrant vesicle acidification and availability of refilled vesicles in the readily releasable pool during rapid recycling. Similar evoked current conversions, albeit in the absence of Tris, have been observed in synaptotagmin 1-deficient mice 15 . Next, we undertook experiments that would allow us to compare Cl − -dependent acidification in synaptic vesicles isolated from Clcn3 +/+ and Clcn3 −/− animals directly.
Inhibitory Clcn3 −/− synaptic vesicles show reduced acidification Our electrophysiological studies suggested that a reduction in CLC-3 expression presents as a reduction in presynaptic function at inhibitory synapses, possibly due to dysfunctional loading of synaptic vesicles with the neurotransmitter. Neurotransmitter loading is directly proportional a r t I C l e S to the H + electrochemical gradient established by the vesicular ATPase (V-ATPase) and assayed in vitro as a change in the level of vesicle acidification 16 . We compared acidification amplitude and rates in CSVs isolated from Clcn3 +/+ and Clcn3 −/− animals as a function of increasing [Cl − ] (Fig. 5a-c) . External Cl − enters the vesicle to neutralize the potential gradient set up by V-ATPase, thereby allowing further vesicle acidification. Although the magnitude of acidification did not differ between Clcn3 +/+ and Clcn3 −/− CSVs (Fig. 5a) , the rate of acidification was significantly different and a function of Cl − concentration (Fig. 5b) .
As the CSV population is composed primarily of excitatory, glutamatergic vesicles, selection of a subset of vesicles was necessary to ascertain whether inhibitory vesicle acidification was more sensitive to CLC-3 expression. We designed a strategy to immunopurify inhibitory vesicles, thereby allowing us to compare acidification in the GABAergic subset Clcn3 −/− and Clcn3 +/+ vesicles. We obtained the enriched inhibitory synaptic vesicle fraction by removing VGLUT1-positive synaptic vesicles from the CSV suspension using magnetic beads coated with anti-VGLUT1 antibodies. We confirmed that this fraction was enriched in VGAT by western blot analysis (Fig. 5d) . Henceforth, we refer to this fraction as inhibitory synaptic vesicles. We compared Cl − -dependent acidification in the Clcn3 +/+ and Clcn3 −/− inhibitory vesicle fraction as well as in the Clcn3 +/+ inhibitory synaptic vesicle fraction depleted of CLC-3 (Fig. 5e) . The magnitude of acidification was significantly greater in Clcn3 +/+ inhibitory vesicles than in Clcn3 −/− inhibitory vesicles. Inhibitory vesicles isolated from Clcn3 −/− mice showed Cl − -dependent levels of acidification identical to that obtained using Clcn3 +/+ inhibitory vesicles depleted of CLC-3, further validating the immunopurification technique. We confirmed the degree of vesicle depletion or enrichment by immunoblot analysis (Fig. 5d-f) .
Immunoisolated vesicles mimic Clcn3 +/+ and Clcn3 −/− vesicles Although a functional comparison of inhibitory vesicles isolated from Clcn3 −/− and Clcn3 +/+ mice showed a marked difference in the levels of acidification, further studies were limited not only by the number of age-matched Clcn3 −/− animals necessary for inhibitory vesicle immunopurification, but also by the hippocampal neurodegenerative process in the Clcn3 −/− mice, which decreases neurotransporter expression as well as vesicle number over time 6 . In light of this fact, coupled with the possibility that Clcn3 −/− animals might develop alternative Cl − influx pathways to compensate for the loss of CLC-3 expression, we developed a rat model in which we could study immunopurified inhibitory vesicles depleted of CLC-3. We confirmed that VGLUT1 was depleted and VGAT enriched in immunoisolated rat synaptic vesicles by western blotting (Fig. 6a). Figure 6b shows Cl − -dependent acidification profiles for excitatory (VGAT-depleted) and inhibitory (VGLUT1-depleted) synaptic vesicles in the presence of constant 10 mM glutamate or GABA, respectively. The magnitude of excitatory vesicle acidification was significantly greater than that of inhibitory vesicle fractions and depended, in part, on the presence of glutamate. Immunopurified excitatory synaptic vesicles acidified in the presence of 10 mM glutamate even in the absence of Cl − in the extravesicular milieu (Fig. 6b) . This is in contrast to data from CSVs reported previously, in which low levels of Cl − were suggested to be necessary to allosterically prime glutamate-induced acidification 6, 17 Figure 6d . Glutamateinduced acidification is significantly slower in the absence of Cl − than in the presence of even low levels of Cl − . Acidification of VGAT-enriched vesicles was slower than that of excitatory vesicles throughout the Cl − concentration range; however, neither vesicle population showed a significant change in the rate of acidification as a function of increasing Cl − . This implies that the acidification rate is likely to be set by V-ATPase turnover, which is relatively constant and independent of an increase in the extravesicular Cl − concentration gradient.
We used magnetic beads coated with anti-CLC-3 antibodies (see above) to deplete inhibitory vesicles of CLC-3 and examined them in acidification experiments (Fig. 7) . The degree of CLC-3 depletion performed on enriched fractions of inhibitory synaptic vesicles was confirmed by western blotting (Fig. 7a) . A comparison of Cl − -dependent acidification profiles for inhibitory vesicles expressing and depleted of CLC-3 matched that obtained for vesicles isolated from Clcn3 +/+ and Clcn3 −/− animals ( Fig. 5c) , providing further validation of the rat model. There was a striking difference in the levels of acidification of inhibitory vesicles depending on the presence of a r t I C l e S CLC-3 (Fig. 7b) . The amplitude of acidification of inhibitory synaptic vesicles was larger and more Cl − -dependent in the presence of CLC-3 than in the CLC-3 depleted population, especially at higher [Cl − ] (Fig. 7c) . The rate of inhibitory vesicle acidification in the presence of CLC-3 was not significantly different from that seen in the CLC-3-depleted fraction at all [Cl − ] (data not shown). Thus, although CLC-3 does not seem to alter the time constant that describes acidification, it has a profound effect on the magnitude of acidification. These data show that CLC-3 has a strong effect on the amplitude of acidification of inhibitory synaptic vesicles, changing both vesicle filling and probability of release.
DISCUSSION
We have shown that the channel protein CLC-3 determines inhibitory synaptic strength presynaptically by altering the magnitude of acidification in VGAT-expressing inhibitory vesicles. CLC-3 is present in VGAT-expressing vesicles localized to perisomatic regions in the CA1 region of the hippocampus, where we focused our electrophysiological studies. Expression of CLC-3 enhanced the quantal size of IPSCs, leading us to hypothesize that the expression of CLC-3 might enhance inhibitory transmission by regulating quantal content. Vesicle acidification, which has been studied most prominently in glutamatergic excitatory vesicles, is Cl − -dependent and driven by the activity of the vesicular H + -ATPase 14 . Our colocalization data (Supplementary Fig. 1) show that CLC-3 is also present on VGLUT1-containing vesicles, consistent with a recent proteomic study of synaptic vesicles in which the relative levels of CLC-3 in glutamatergic and GABAergic vesicles were found to be comparable 18 . CLC-3 has been examined as a conductance pathway that facilitates vesicle acidification and filling at excitatory synapses 1, 6 . Recent data suggest that VGLUT1 provides a parallel vesicular Cl − shunt pathway to ensure efficient and rapid acidification and transmitter filling 6 . In our experiments, acidification profiles in CSVs from Clcn3 +/+ and Clcn3 −/− mice showed no significant difference in the magnitude of acidification, a subject of controversy in the literature 1, 6 , although the rate of acidification differed as a function of CLC-3 expression at low extravesicular Cl − concentrations (Fig. 5b) . The CSV pool is made up predominantly of glutamatergic vesicles, so data from the minority populations of GABAergic, cholinergic and dopaminergic vesicles are obscured. Our experimental goal was to measure acidification directly in immunoisolated, subset-selected, VGAT-expressing vesicles. Antibody-coated beads have been used previously to examine both neurotransmitter uptake and acidification in synaptic vesicles 11 . In these studies, acidification in the VGATisolated bead fraction was significantly lower than in vesicles from the synaptophysin-isolated beads (presumably, mainly VGLUT1-positive).
We reasoned that this reduction in acidification in VGAT-positive vesicles could have been a consequence of antibody binding to the transporter itself during the isolation process and thereby inhibiting function. To avoid this possibility in our experiments, we developed a negative selection strategy to enrich the subset of interest, thereby circumventing possible antibody-induced inhibition of transporter function. Our immunoenriched VGLUT1-depleted vesicles (inhibitory population) also showed a significant decrease in acidification compared to VGLUT1-enriched (excitatory) vesicles (Fig. 6c) , as seen in the positive-selection bead studies 11 . Both populations of vesicles, inhibitory and excitatory, show [Cl − ]-dependent acidification, implying that a Cl − influx pathway has a general role in acidification and filling.
Comparison of the magnitude and time course of acidification of inhibitory vesicles in both the mouse experiments and the rat model lacking CLC-3 confirmed that CLC-3 expression provides a substantial contribution to the necessary Cl − influx during vesicle acidification and filling. Immunoisolated VGAT-enriched vesicles depleted of CLC-3 showed a significant loss of acidification in the presence of increasing concentrations of Cl − when compared to inhibitory vesicle populations expressing CLC-3 (Fig. 7c) . CLC-3 seems to facilitate inhibitory neurotransmitter loading by providing a shunt conductance to reduce the voltage gradient established by the V-ATPase. Neither the CLC-3-expressing vesicles nor those that did not express CLC-3 showed significant Cl − dependence in the time course of acidification. This might reflect the fact that the channel and the V-ATPase work in tandem and the time constants that describe the activity of the two transport proteins do not differ significantly. CLC-3 activity then enhances the availability of protons at a rate that is consistent with the turnover of V-ATPase. Note that the time constants that describe acidification in our experiments are on the order of seconds. By contrast, the pH-dependent change in fluorescence from quantum dots (Q-dots) loaded into synaptic vesicles occurs on the order of tens of milliseconds 14 . The difference in time course between the two experimental techniques is likely to be due to the fact that isolated vesicles in the in vitro acidification experiments lack any significant internal Cl − initially whereas those vesicles in the Q-dot experiments have high levels of internal Cl − taken up during the recycling process. Thus, high internal Cl − concentrations seem to be highly beneficial in promoting rapid reacidification and, therefore, refilling.
A positive intravesicular potential is not needed to facilitate the influx of the neutral species GABA as it is for negatively charged glutamate, so why does the inhibitory vesicle need to be acidified to fill? Two models of VGAT function have been proposed to answer this question. In reconstitution studies of the vesicular inhibitory amino acid transporter (VIAAT, also known as VGAT), VGAT functions as a Cl − -GABA symporter: GABA enters the vesicle accompanied by a r t I C l e S two Cl − ions 9 . The reconstituted studies were carried out using liposomes that did not initially contain Cl − . In this scenario, the influx of Cl − driving GABA uptake is a function of the potential gradient, set up presumably by the activity of the V-ATPase. What is not clear is how the uptake of GABA, and therefore the influx of Cl − , will change as vesicles recycle; vesicles engulf high Cl − equal to that in the synaptic cleft after reuptake, so the equilibrium potential for Cl − should direct its movement out of the vesicle and thereby inhibit GABA uptake. The studies in ref. 9 were carried out with liposomes of minimal transporter composition without CLC-3 present. Thus, CLC-3 in native VGAT vesicles might provide a parallel efflux pathway to clear the vesicle of high Cl − concentrations. This would allow the transporter, coupled to the Cl − gradient, to work at maximum rates for rapid refilling during the recycling process. The primary role for CLC-3 in this model would be as an anion efflux pathway that maintains constant transmitter uptake with minimal dependence on the pH gradient, explaining competent filling in the absence of acidification.
A competing view of VGAT function holds that the transporter acts as a coupled proton-GABA antiporter. This model is supported by the observation that GABA uptake depends more strongly on the magnitude of the pH gradient (∆pH) than the voltage gradient (∆Ψ) in the vesicle lumen 14, 19 . In this case, increases in luminal Cl − would shift the energy balance in the vesicle, making ∆pH the principal driving force over the potential gradient (∆Ψ) and thus favoring the availability of protons to exchange for GABA in vesicle loading. Our Tris data support the hypothesis that GABA loading depends on both CLC-3 and pH. Tris loading reduces inhibitory synaptic transmission more in Clcn3 −/− than in Clcn3 +/+ neurons, showing that alkalinization of vesicles reduces GABA loading and that inhibitory vesicles that lack CLC-3 are more alkaline than CLC-3-expressing vesicles. Our data favor the model in which VGAT acts as a proton-GABA exchanger in that the exchanger would function when Cl − concentrations are high in the vesicle lumen during rapid recycling. Furthermore, the expression of CLC-3 would ensure maximum ∆pH and hence the availability of protons for rapid GABA loading during vesicle recycling at inhibitory synapses to maintain rapid firing 20, 21 .
Our electrophysiological studies showed not only that quantal size was decreased in Clcn −/− neurons but also that there was a significant reduction in the frequency of events (Fig. 3b) . This could mean that the release probability at the inhibitory synapse was decreased with alkalinized vesicles, as observed in capacitance experiments on Clcn3 −/− pancreatic beta cells 22 and in bafilomycin-treated hematopoietic cells in response to secretagogues 23 . Vesicle alkalinization decreases both the amplitude and frequency of GABAergic mIPSCs in hippocampal slice preparations after treatment with bafilomycin, an effective V-ATPase inhibitor 24 . The decrement in vesicle release probability after bafilomycin treatment could be due to the release of empty vesicles or to the fact that vesicle acidification is a necessary prerequisite for release. Unchanged vesicle recycling has been observed by FM1-43 imaging in isolated, cultured hippocampal neurons after bafilomycin treatment and has been taken as evidence for the hypothesis that vesicle release is independent of the state of vesicle filling or acidification 24 . Our data do not distinguish between a scenario in which all vesicles are released, with empty vesicles contributing to a decrease in release probability, and an alternative scenario in which vesicle release depends on a minimum level of acidification and filling. We cannot rule out the possibility that the decrease in mIPSP frequency in the Clcn3 −/− preparations might be due to the release of vesicles with content low enough to make them indistinguishable from baseline noise. Evidence against this possibility comes from experiments in which Tris added to the external solution reduced the amplitude of mIPSCs as a result of the resultant vesicle alkalinization but did not reduce mIPSC frequency (Fig. 4) . This observation suggests that alkalinization of vesicles alone does not change release probability. The decrement in release frequency seen in the Clcn3 −/− slices but not in the Tris experiments suggests that CLC-3 expression may facilitate release probability, possibly by interacting with docking protein machinery. Loss of CLC-3 expression then would decrease spontaneous release probability.
It is likely that not all inhibitory synapses express CLC-3 presynaptically, at least in the two main types of perisomatically synapsing interneurons 25 . Our data do not address this possibility directly but suggest this may be the case as depletion of VGAT-containing vesicles of CLC-3 leaves a significant fraction of vesicles that are capable of a limited range of acidification. This leaves the possibility that not all inhibitory vesicles need to acidify to fill or that alternative splice variants of VGAT may be associated with CLC-3-deficient vesicles and function in an unidentified mode. However, it is clear that CLC-3, whether transporter or channel in the intracellular compartment, can enhance synaptic efficacy through a presynaptic mechanism that regulates the acidification and filling of synaptic vesicles. Our observations extend the role of Cl − in inhibitory transmission from that of a postsynaptic permeant species to a presynaptic regulatory element.
METhODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureneuroscience/.
localization of clc-3 on VgAT-positive synaptic vesicles by immuno-electron microscopy. Microbeads (Spherotech, Inc.) with attached VGAT-positive synaptic vesicles were pelleted by centrifugation, and the pellet was fixed with 0.15% glutaraldehyde and 4% paraformaldehyde for 1 h at 4 °C, washed with PBS, and embedded in LR white resin (Electron Microscopy Science) at 45 °C in a vacuum oven for 48 h. Preparations were sectioned (90 nm) with a ReichertJung Ultracut E microtome. Sections were stained with anti-CLC-3 730-744 (1:100). Preimmune rabbit IgG (Sigma) was used as a negative control. CLC-3 was visualized using goat anti-rabbit antibodies conjugated to 15-nm gold particles. Images were captured using a Tecnai F30 transmission electron microscope (TEI).
Acidification of synaptic vesicles. Acridine orange, a pH-sensitive dye, was used as an indicator to evaluate acidification of synaptic vesicles. Changes in fluorescence were measured with spectrofluorometer FluoroMax 3 (Horiba Jobin Yvon) using excitation at 492 nm and emission at 528 nm 28 at a time increment of 0.5 s. Synaptic vesicles (25-50 µg) were resuspended in 10 mM 3-(N-morpholino) propanesulfonic acid (MOPS)-CsOH with 320 mM sucrose and 4 mM MgSO 4 , pH 7.4 and equilibrated at 32 °C. Final reaction volume was 1 ml and contained 1 µM acridine orange, 2 mM ATP to initiate acidification, 10 mM neurotransmitter when indicated (either GABA or glutamate) and varying Cl − concentrations (0, 5, 35, 80 and 150 mM choline chloride). The reaction was performed with identical protein amounts of all fractions at constant mixing with a magnetic stirrer. To isolate the effect of Cl − concentration on acidification, the buffer was devoid of K + and Na + . A protonophore carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone (FCCP) at 40 µM was added at the end of reaction to equalize the intravesicular pH with that of the medium. High reproducibility of this methodology in our preparations can be seen on Supplementary Figure 4 . data analysis and miscellaneous procedures. All data in this study, unless otherwise indicated, are mean values ± s.e.m. with the number of trials, cells or animals in parentheses. Synaptic vesicle studies represent means from at least three preparations. Confidence was assessed by either two-tailed unpaired Student's t-test between datasets or one-way ANOVA using Origin Pro 8.2 (Northampton) or PCLAMP (Molecular Devices) software as indicated in the figure legends. The time constant (τ) for synaptic vesicle acidification was determined from single exponential fits to the fluorescence data using Origin Pro 8.2 software.
